UnknownNot Applicable

NGAL and Hepcidin Levels in Hemodialysis Patients in Assiut University Hospital

70 participantsStarted 2019-09-04

Plain-language summary

To assess the pattern of NGAL and Hepicidin in relation to anemia in End Stage Renal Disease Patients on regular hemodialysis in Assiut University Hospital and study the relation between both NGAL and Hepicidin.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults \> 18 years.
✓. Age and sex matched.
✓. No active infection or inflammation.
✓. Adults \> 18 years.
✓. ESRD patients on regular hemodialysis.
✓. Hgb \< 11g/dl.
✓. No apparent infection or inflammation.
✓. Adults \> 18 years.

Exclusion criteria

✕. Children and those \>60 Years.
✕. Pregnant female.
✕. Patients with severe infection or with other immune system diseases.

What they're measuring

Assessment of Neutrophil Gelatinase Associated Lipocalin (NGAL) and Hepcidin levels in Hemodialysis patients in Assiut University Hospital, 60 patients and 12 controls will be recruited.

Timeframe: Bseline

Trial details

NCT IDNCT04083664

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-09

Contact for this trial

Mohammed Hussein, Master

+201005453884 drmohmedh@gmail.com

View on ClinicalTrials.gov More CKD (Chronic Kidney Disease) Stage 5D trials